Return to homepagePandemic Pact

Clinical Trial Management Support Services for ACTIV-2

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N93021D00035-0-759302200001-1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2022

  • Known Financial Commitments (USD)

    $48,583,194

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    MARY GLESSNER

  • Research Location

    United States of America

  • Lead Research Institution

    PPD DEVELOPMENT LP

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Comprehensive and Rapid Response for NIAID Research Program (CARRRP): Provide the capacity and capability for a broad range of services necessary to support and conduct biomedical research in support of the NIAID mission and the management of activities specified under the Statement of Work and associated Task Orders. The purpose of this task order is to acquire comprehensive/full clinical trial management support services to the ongoing Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-2) clinical trial. The objective of ACTIV-2 is to evaluate the safety and efficacy of investigational agents for the treatment of symptomatic non-hospitalized adults with COVID-19.